Swain, S. M., Baselga, J., Miles, D., Im, Y., Quah, C., Lee, L. F., & Cortés, J. (2014). Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: Results from the randomized phase III study CLEOPATRA. Oxford University Press.

Swain, S. M., J. Baselga, D. Miles, Y.-H Im, C. Quah, L. F. Lee, et J. Cortés. Incidence of Central Nervous System Metastases in Patients With HER2-positive Metastatic Breast Cancer Treated With Pertuzumab, Trastuzumab, and Docetaxel: Results From the Randomized Phase III Study CLEOPATRA. Oxford University Press, 2014.

Swain, S. M., et al. Incidence of Central Nervous System Metastases in Patients With HER2-positive Metastatic Breast Cancer Treated With Pertuzumab, Trastuzumab, and Docetaxel: Results From the Randomized Phase III Study CLEOPATRA. Oxford University Press, 2014.